MoneyWorks4Me

Sanofi India - Quaterly Results

26 Apr 2022 Evaluate
A slight decline in the revenue of Rs. 7070.00 millions was seen for the March 2022 quarter as against Rs. 7251.00 millions during year-ago period.Profit after tax for the quarter ended March 2022 reported a huge growth of 63.40% to Rs. 2384.00  millions from Rs. 1459.00 millions.Operating Profit saw a handsome growth to 2189.00 millions from 2157.00 millions in the quarter ended March 2022.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202203 202103 % Var 202203 202103 % Var 202112 202012 % Var
Sales 7070.00 7251.00 -2.50 7070.00 7251.00 -2.50 29566.00 29019.00 1.88
Other Income 244.00 263.00 -7.22 244.00 263.00 -7.22 744.00 898.00 -17.15
PBIDT 2189.00 2157.00 1.48 2189.00 2157.00 1.48 8369.00 8029.00 4.23
Interest 4.00 4.00 0.00 4.00 4.00 0.00 18.00 18.00 0.00
PBDT 3366.00 2153.00 56.34 3366.00 2153.00 56.34 13243.00 7594.00 74.39
Depreciation 109.00 204.00 -46.57 109.00 204.00 -46.57 667.00 822.00 -18.86
PBT 3257.00 1949.00 67.11 3257.00 1949.00 67.11 12576.00 6772.00 85.71
TAX 873.00 490.00 78.16 873.00 490.00 78.16 3132.00 1996.00 56.91
Deferred Tax 42.00 -50.00 -184.00 42.00 -50.00 -184.00 -228.00 -114.00 100.00
PAT 2384.00 1459.00 63.40 2384.00 1459.00 63.40 9444.00 4776.00 97.74
Equity 230.00 230.00 0.00 230.00 230.00 0.00 230.00 230.00 0.00
PBIDTM(%) 30.96 29.75 4.08 30.96 29.75 4.08 28.31 27.67 2.31
Peers
Company Name CMP
Sun Pharma. Inds. 1835.50
Dr. Reddys Labs. 1171.10
Cipla 1371.45
Lupin 2144.70
Zydus Lifesciences 1153.00
View more..